Other substances

Ondansetron

A serotonin receptor antagonist.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

Ondansetron on PubChem

Marketed as

ONDANSETRON; ONDISSOLVE ODF; ZOFRAN; ZOPHREN; ZUPLENZ

 

Structure image - Ondansetron

CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C


 

Supporting references

Link Tested on Impact factor Notes Publication date
Computational molecular docking and virtual screening revealed promising SARS-CoV-2 drugs
3CLpro PapainLpro RdRpol Small molecule In silico 		in silico

Predicted to inhibit SARS-CoV-2 3C-like protease.

 Jan/18/2021

AI-suggested references

Link Publication date
Reduced Mortality With Ondansetron Use in SARS-CoV-2-Infected Inpatients.
Jul/14/2021
Export (.csv)